BR · digital prescription · healthcare · pharmacy
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Mar 2026 · $18M
Prosus lead, Matrix, Floating Point, Jefferson River Capital
Reported by LatamList
Missing a round, or an investor who was in one? Tell us.